Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes

Diabetes

Volumn 45, Issue 9, 1996, Pages 1193-1196

  Dotta, Francesco ^a,d   Gianani, Roberte ^c   Previti, Marcello ^a   Lenti, Luisa ^a   Dionisi, Sabrina ^e   D'Erme, Maria ^a   Eisenbarth, George S ^c   Di Mario, Umberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b University of RC   (Italy)

^c UNIVERSITY OF COLORADO   (United States)

^d DEM Foundation   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GANGLIOSIDE ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSIS; DISEASE COURSE; FOLLOW UP; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0029818740     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1193     Document Type: Article

References (24)

1. Hakomori SI: Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Ann Rev Biochem. 50:733-764, 1981
2. Atkinson MA, MacLaren NK: Mechanism of disease: the pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1435, 1994
3. Atkinson MA, MacLaren NK: Islet cell autoantigens in insulin dependent diabetes. J Clin Invest 92:1608-1616, 1993
4. Bottazzo GF, Florin-Christensen A, Doniach D: Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii:1279-1283, 1974
5. Palmer JP, Asplin CM, Clemons P, Lyon K, Tatpati O, Raghu P, Paquette TL: Insulin autoantibodies in insulin dependent diabetes before insulin treatment. Science 222:1337-1339, 1983
6. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
7. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YLS, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Leiter EH, Eisenbarth GS: Islet cell autoantigen 69kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92:359-371, 1993
8. Gillard B, Thomas JW, Nell LJ, Marcus DM: Antibodies against ganglioside GT3 in sera of patients with type 1 diabetes mellitus. J Immunol 142:3826-3832, 1989
9. Gianani R, Pugliese A, Bonner Weir S, Schiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alpert CA, Jackson RA, Eisenbarth GS: Prognostically significant heterogeneity of cytoplasmic islet cell autoantibodies in relatives of patients with type 1 diabetes. Diabetes 41:347-353, 1992
10. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385-389, 1992
11. Atkinson MA, Kaufman DL, Campbell L, Tobin AJ, MacLaren NK: Islet cell cytoplasmic antibody reactivity to glutamate decarboxylase in insulin dependent diabetes. J Clin Invest 91:350-356, 1993
12. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS: Cytoplasmic islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 34:617-619, 1985
13. Colman PG, Nayak RC, Campbell IL, Eisenbarth GS: Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37:645-652, 1988
14. Dotta F, Colman PG, Lombardi D, Scharp DW, Andreani D, Pontieri GM, Di Mario U, Lenti L, Eisenbarth GS, Nayak RC: Ganglioside expression in human pancreatic islets. Diabetes 38:1478-1483, 1989
15. Dotta F, Tiberti C, Previti M, Anastasi E, Andreani D, Lenti L, Pontieri GM, Gianani R, Appel MC, Eisenbarth GS, Di Mario U: Rat pancreatic ganglioside expression: differences between a model of autoimmune islet cell destruction and a normal strain. Clin Immunol Immunopath 66:143-149, 1993
16. Dotta F, Peterson LB, Previti M, Metzger J, Tiberti C, Anastasi E, Zoppitelli P, Wicker LS, Di Mario U: Pancreatic islet ganglioside expression in non obese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune cell destruction. Endocrinology 130:37-42, 1992
17. Makino S, Kunimoto K, Muraoka J, Mizushima J, Katagiri K, Tochino K: Breeding of a non obese diabetic strain of mice. Exp Anim 29:1-13, 1980
18. Dotta F, Previti M, Lenti L, Dionisi S, Casetta B, D'Erme M, Eisenbarth GS, Di Mario U: GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet specific molecule. Diabetologia 38:1117-1121, 1995
19. Svennerholm L, Fredman P: A procedure for quantitative isolation of brain gangliosides. Biochem Biophys Acta 617:97-109, 1980
20. Williams MA, McCluer RH: The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 35:266-269, 1980
21. Svennerholm L: Chromatographic separation of human brain gangliosides. J Neurochem 10:613-623, 1963
22. Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, Steplewski Z, Koprowski H: A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55-56, 1981
23. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS: Life table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with type 1 diabetes. Diabetes 38:1320-1325, 1989
24. Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L: Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol 238:75-79, 1991